These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33281265)

  • 21. Curcumin and its analogues (PGV-0 and PGV-1) enhance sensitivity of resistant MCF-7 cells to doxorubicin through inhibition of HER2 and NF-kB activation.
    Meiyanto E; Putri DD; Susidarti RA; Murwanti R; Sardjiman ; Fitriasari A; Husnaa U; Purnomo H; Kawaichi M
    Asian Pac J Cancer Prev; 2014; 15(1):179-84. PubMed ID: 24528023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
    Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
    Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
    Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
    Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hTERT Gene Expression by Silibinin-Loaded PLGA-PEG-Fe3O4 in T47D Breast Cancer Cell Line.
    Ebrahimnezhad Z; Zarghami N; Keyhani M; Amirsaadat S; Akbarzadeh A; Rahmati M; Mohammad Taheri Z; Nejati-Koshki K
    Bioimpacts; 2013; 3(2):67-74. PubMed ID: 23878789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silibinin reverses drug resistance in human small-cell lung carcinoma cells.
    Sadava D; Kane SE
    Cancer Lett; 2013 Oct; 339(1):102-6. PubMed ID: 23879966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.
    Zhou S; Li J; Xu H; Zhang S; Chen X; Chen W; Yang S; Zhong S; Zhao J; Tang J
    Gene; 2017 Jul; 622():1-12. PubMed ID: 28431975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin for the Prevention of Epithelial-Mesenchymal Transition in Endoxifen-Treated MCF-7 Breast Cancer Cel.
    Paramita P; Wardhani BW; Wanandi SI; Louisa M
    Asian Pac J Cancer Prev; 2018 May; 19(5):1243-1249. PubMed ID: 29801408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The apoptotic effects of silibinin on MDA-MB-231 and MCF-7 human breast carcinoma cells.
    Bayram D; Çetin ES; Kara M; Özgöçmen M; Candan IA
    Hum Exp Toxicol; 2017 Jun; 36(6):573-586. PubMed ID: 27402681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localized leptin release may be an important mechanism of curcumin action after acute ischemic injuries.
    Deng ZH; Liao J; Zhang JY; Hao XH; Liang C; Wang LH; Xue H; Zhang K; Yan GT
    J Trauma Acute Care Surg; 2013 Apr; 74(4):1044-51. PubMed ID: 23511143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes.
    Papanikolaou V; Stefanou N; Dubos S; Papathanasiou I; Palianopoulou M; Valiakou V; Tsezou A
    Cell Oncol (Dordr); 2015 Apr; 38(2):155-64. PubMed ID: 25539992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiproliferative effect of an analog of curcumin bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione in human breast cancer cells.
    Kumaravel M; Sankar P; Rukkumani R
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1900-7. PubMed ID: 23242714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
    Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
    Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticancer effect of curcumin inhibits cell growth through miR-21/PTEN/Akt pathway in breast cancer cell.
    Wang X; Hang Y; Liu J; Hou Y; Wang N; Wang M
    Oncol Lett; 2017 Jun; 13(6):4825-4831. PubMed ID: 28599484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined treatment with silibinin and either sorafenib or gefitinib enhances their growth-inhibiting effects in hepatocellular carcinoma cells.
    Gu HR; Park SC; Choi SJ; Lee JC; Kim YC; Han CJ; Kim J; Yang KY; Kim YJ; Noh GY; No SH; Jeong JH
    Clin Mol Hepatol; 2015 Mar; 21(1):49-59. PubMed ID: 25834802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anticancer effects of biodegradable nanomagnetic dual natural components on the leptin gene expression in lung cancer.
    Askari S; Salehi R; Zarghami N; Akbarzadeh A; Rahmati-Yamchi M
    Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1753-63. PubMed ID: 26593227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin.
    Grill AE; Koniar B; Panyam J
    Drug Deliv Transl Res; 2014 Aug; 4(4):344-52. PubMed ID: 25422796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Effects of Aminonaphthoquinone Derivatives in Combination with Curcumin Against ER-positive Breast Cancer and Related Tumours.
    Pereira MC; Mohammed R; VAN Otterlo WAL; DE Koning CB; Davids H
    Anticancer Res; 2017 Dec; 37(12):6749-6759. PubMed ID: 29187453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating in vitro anti-leishmanial effects of silibinin and silymarin on Leishmania major.
    Faridnia R; Kalani H; Fakhar M; Akhtari J
    Ann Parasitol; 2018; 64(1):29–35. PubMed ID: 29716183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Inhibitory Effect of Curcumin on Hypoxia Inducer Factors (Hifs) as a Regulatory Factor in the Growth of Tumor Cells in Breast Cancer Stem-Like Cells.
    Sarighieh MA; Montazeri V; Shadboorestan A; Ghahremani MH; Ostad SN
    Drug Res (Stuttg); 2020 Nov; 70(11):512-518. PubMed ID: 32961574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer.
    Ishikawa M; Kitayama J; Nagawa H
    Clin Cancer Res; 2004 Jul; 10(13):4325-31. PubMed ID: 15240518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.